Bovine Casein Hydrolysate (C12 Peptide) Reduces Blood Pressure in Prehypertensive Subjects

American Journal of Hypertension

Volumn 20, Issue 1, 2007, Pages 1-5

  Cadée, Jenny A ^a   Chang, Chou Yue ^d   Chen, Chien Wei ^b   Huang, Chien Ning ^c   Chen, Su Lin ^d   Wang, Chin Kun ^d  

^a DMV International   (Netherlands)

^b Chung Shan Medical University Hospital ^*

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ACE inhibitor; C12 Peptide; casein hydrolysate; Hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; BOVINE CASEIN HYDROLYSATE; C12 PEPTIDE; PLACEBO; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG;

ADULT; ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD CHEMISTRY; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN MANIFESTATION; SYSTOLIC BLOOD PRESSURE; TABLET FORMULATION; TAIWAN; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS;

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CASEINS; CATTLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 33845723266     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.06.005     Document Type: Article

References (28)

1. Mackay J., and Mensah G.A. The Atlas of Heart Disease and Stroke (2004), World Health Organization and US Centers for Disease Control and Prevention
2. Chobanian A.V., Bakris G.L., and Black H.R. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252
3. Yokokawa K., Chiba H., and Yoshikawa M. Peptide inhibitors for angiotensin É-converting enzyme from thermolysin digest of dried bonito. Biosci Biotech Biochem 56 (1992) 1541-1545
4. Matsui T., Matsufuji H., Seki E., Osajima K., Nakashima M., and Osajima Y. Inhibition of angiotensin-converting enzyme by bacillus licheniformis alkaline proteases hydrolysates derived from sardine muscle. Biotec Biochem 57 (1993) 922-925
5. Yamamoto N., Akino A., and Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 77 (1994) 917-922
6. Sato M., Hosokawa T., Yamaguchi T., Nakano T., Muramoto K., and Kaharh T. Angiotensin I-converting enzyme inhibitory peptides derived from wakame (undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J Agric Food Chem 50 (2002) 6245-6252
7. Hata Y. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64 (1996) 767-771
8. Kawasaki T. Antihypertensive effect of Valyl-Tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J Human Hypertens 14 (2000) 519-523
9. Matsui T., Hui Li C., Tanaka T., Maki T., Osajima Y., and Matsomoto K. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biol Pharm Bull 23 (2000) 427-431
10. Loponen J. Angiotensin converting enzym inhibitory peptides in Finnish cereals: a database survey. Agr Food Sci 13 (2004) 39-45
11. Meisel H. Overview on milk protein-derived peptides. Int Dairy J 8 (1998) 363-373
12. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., and Takano T. Purification and characterization of angiotensin-I converting enzyme inhibitors from sour milk. J Dairy Sci 78 (1995) 777-783
13. Takano T. Milk derived peptides and hypertension reduction. Int Dairy J 8 (1998) 375-381
14. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 77 (2003) 326-330
15. Karaki H., Doi K., Sugano S., Uchiwa H., Sugai R., Murakami U., and Takemoto S. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol 96C (1990) 367-371
16. Yamamoto N., and Takano T. Antihypertensive peptides derived from milk proteins. Nahrung 43 (1999) S159-S164
17. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., and Nurminen M.L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 69 (2002) 103-111
18. Sekiya S., Kobayashi Y., Kita E., Imamura Y., and Toyama S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J Jpn Soc Nutr Food Sci 45 (1992) 513-517
19. 12 Peptide) in human essential hypertension. Am J Hypertens 17 (2004) 1056-1058
20. Mayes D., Furuyama S., Kem D.C., and Nugent C.A. A radioimmunoassay for plasma aldosterone. J Clin Endocrinol Metab 30 (1970) 682-685
21. Hermann K., Ganten D., Unger T., Bayer C., and Lang R.E. Measurement and characterization of angiotensin peptides in plasma. Clin Chem 34 (1988) 1046-1051
22. Emanuel R.L., Cain J.P., and William G.H. Double-antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 81 (1973) 632-640
23. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., Lin P.-H., and Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336 (1997) 1117-1124
24. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., Simons-Morton D.G., Karanja N., and Lin P.-H. Effects of blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344 (2001) 3-10
25. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., and Roccella E.J. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289 (2003) 2560-2572
26. Geleijnse J.M., Kok F.J., and Grobbee D.E. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hyp 17 (2003) 471-480
27. Blumenthal J.A., Sherwood A., Gullette E.C.D., Babyak M., Waugh R., Georgiades A., Craighead L.W., Tweedy D., Feinglos M., Appelbaum M., Hayano J., and Hinderliter A. Exercise and weight loss reduce blood pressure in men and women with mild hypertension. Arch Intern Med 160 (2000) 1947-1958
28. Imai Y., Sato K., Abe K., Sasaki S., Nihei M., Yoshinaga K., and Sekino H. Effect of weight loss on blood pressure and drug consumption in normal weight patients. Hypertens 8 (1986) 223-228